BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23068316)

  • 1. A case of mistaken identity? Vaccinia virus in a live camelpox vaccine.
    Yousif AA; Al-Ali AM
    Biologicals; 2012 Nov; 40(6):495-8. PubMed ID: 23068316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More cell culture passaged Camelpox virus sequences found resembling those of vaccinia virus.
    Khalafalla AI; Al Hosani MA; Ishag HZA; Al Muhairi SS
    Open Vet J; 2020 Aug; 10(2):144-156. PubMed ID: 32821659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time PCR assay to identify variants of Vaccinia virus: implications for the diagnosis of bovine vaccinia in Brazil.
    de Souza Trindade G; Li Y; Olson VA; Emerson G; Regnery RL; da Fonseca FG; Kroon EG; Damon I
    J Virol Methods; 2008 Sep; 152(1-2):63-71. PubMed ID: 18602170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real time PCR: a rapid tool for potency estimation of live attenuated camelpox and buffalopox vaccines.
    Prabhu M; Siva Sankar MS; Bhanuprakash V; Venkatesan G; Bora DP; Yogisharadhya R; Balamurugan V
    Biologicals; 2012 Jan; 40(1):92-5. PubMed ID: 22019252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.
    Hooper JW; Custer DM; Schmaljohn CS; Schmaljohn AL
    Virology; 2000 Jan; 266(2):329-39. PubMed ID: 10639319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates.
    Hooper JW; Custer DM; Thompson E
    Virology; 2003 Feb; 306(1):181-95. PubMed ID: 12620810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.
    Golden JW; Josleyn MD; Hooper JW
    Vaccine; 2008 Jun; 26(27-28):3507-15. PubMed ID: 18485547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery and molecular characterization of live Camelpox virus from skin 12 months after onset of clinical signs reveals possible mechanism of virus persistence in herds.
    Yousif AA; Al-Naeem AA
    Vet Microbiol; 2012 Oct; 159(3-4):320-6. PubMed ID: 22595140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge.
    Pulford DJ; Gates A; Bridge SH; Robinson JH; Ulaeto D
    Vaccine; 2004 Sep; 22(25-26):3358-66. PubMed ID: 15308360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
    Parkinson JE; Smith GL
    Virology; 1994 Oct; 204(1):376-90. PubMed ID: 8091668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of a live attenuated camelpox vaccine from a local field isolate of the virus.
    Abdellatif MM; Ibrahim AA; Khalafalla AI
    Rev Sci Tech; 2014 Dec; 33(3):831-8. PubMed ID: 25812207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome Sequencing of a Camelpox Vaccine Reveals Close Similarity to Modified
    Marcacci M; Khalafalla AI; Al Hammadi ZM; Monaco F; Cammà C; Yusof MF; Al Yammahi SM; Mangone I; Valleriani F; Alhosani MA; Decaro N; Lorusso A; Almuhairi SS; Savini G
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32717784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic sequence of a clonal isolate of the vaccinia virus Lister strain employed for smallpox vaccination in France and its comparison to other orthopoxviruses.
    Garcel A; Crance JM; Drillien R; Garin D; Favier AL
    J Gen Virol; 2007 Jul; 88(Pt 7):1906-1916. PubMed ID: 17554021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Another case of mistaken identity? Vaccinia virus in another live Camelpox vaccine.
    Saud Z; Butt TM
    Biologicals; 2020 May; 65():39-41. PubMed ID: 32334926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory-acquired vaccinia exposures and infections--United States, 2005-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):401-4. PubMed ID: 18418346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camelpox virus encodes a schlafen-like protein that affects orthopoxvirus virulence.
    Gubser C; Goodbody R; Ecker A; Brady G; O'Neill LAJ; Jacobs N; Smith GL
    J Gen Virol; 2007 Jun; 88(Pt 6):1667-1676. PubMed ID: 17485525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genome of camelpox virus.
    Afonso CL; Tulman ER; Lu Z; Zsak L; Sandybaev NT; Kerembekova UZ; Zaitsev VL; Kutish GF; Rock DL
    Virology; 2002 Mar; 295(1):1-9. PubMed ID: 12033760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus.
    Duraffour S; Andrei G; Topalis D; Krečmerová M; Crance JM; Garin D; Snoeck R
    J Virol; 2012 Jul; 86(13):7310-25. PubMed ID: 22532673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection induced in mice against a lethal orthopox virus by the Lister strain of vaccinia virus and modified vaccinia virus Ankara (MVA).
    Abdalrhman I; Gurt I; Katz E
    Vaccine; 2006 May; 24(19):4152-60. PubMed ID: 16603280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.